The Therapeutic Effect of Different Exercise Intensities on Weight Loss in Obese Children
Launched by THIRD AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · Jan 3, 2024
Trial Information
Current as of November 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of exercise can help with weight loss in obese children. Researchers want to see if high-intensity interval training (HIIT), which involves short bursts of very intense exercise, is more effective than moderate-intensity continuous training (MICT), where children exercise at a steady, moderate pace. Both groups will follow a balanced diet while participating in a supervised exercise program for three months. The goal is to understand how these exercise methods affect weight loss and overall health in children aged 6 to 16 who are classified as obese.
To be eligible for this study, children must be between 6 and 16 years old, have a body mass index (BMI) that indicates obesity, and be able to safely participate in exercise. Their guardians will need to understand and sign consent forms. Participants will be monitored over a year, with follow-up assessments at different points to track their progress. This research aims to provide valuable insights into how exercise intensity affects weight loss and health in children and may help create better exercise guidelines for promoting healthy habits in this age group.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The guardian understands and signs the informed consent. If the subject is at least 8 years old, the informed consent must be signed.
- • 2. Age 6\~16 years old, male and female;
- • 3. BMI≥ \"sex-age BMI reference point for obesity screening of school-age children aged 6-18 years\";
- • 4. no disability;
- • 5. Joint cardiopulmonary function assessment showed that participation was safe;
- • 6. At least one year of follow-up is expected.
- Exclusion Criteria:
- • 1. Have high blood pressure (defined as systolic or diastolic blood pressure values above the 95th percentile), any history or evidence of heart disease and/or abnormal resting or stress echocardiography or a combined cardiopulmonary function assessment indicating that participation is not safe;
- • 2. have any chronic disease, such as chronic asthma, kidney disease, type 1 diabetes, epilepsy, etc.;
- • 3. suffering from organic diseases, such as ovarian tumors, hamartoma, etc.;
- • 4. A smoking habit or orthopedic/neurological condition that may limit exercise ability;
- • 5. Confirmed attention deficit hyperactivity disorder and steroid use.
About Third Affiliated Hospital, Sun Yat Sen University
The Third Affiliated Hospital of Sun Yat-sen University is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its comprehensive resources and multidisciplinary expertise to facilitate cutting-edge studies that aim to improve patient outcomes and contribute to the global body of medical knowledge. With a focus on collaboration and patient-centered care, the Third Affiliated Hospital is dedicated to fostering advancements in medical science and ensuring the highest standards of ethical practice in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported